Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Three images in a row: two of bacteria and virus cells, one of someone holding a vial and needle containing treatment

About

The mission of the Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is to pump-prime innovative Oxford-based immuno-oncology research and build capacity in cancer immunology.

OCION will provide small, short-term awards that will enable the development of proof-of-concept projects, technologies, assays and platforms to a stage at which more long-term external funding can be sought. We would also welcome proposals that build our capabilities in data analytics and integration.

Collaborative projects that cross discipline boundaries are encouraged. Fundamental science and clinical research proposals are welcome. 

Eligibility and how to apply

The OCION funding scheme is now closed. Check back here for updates on future rounds. 

 The lead applicant must be:

-          an OCION member (email cancer@medsci.ox.ac.uk to join)

-          employed by either the University of Oxford or OUH NHS Trust for the duration of the award.

Postdoctoral Researchers and Clinical Research Fellows who are not yet independent may apply. Collaborations with cancer researchers and clinicians are encouraged to help deliver the project.

To be successful applications should:

1)      demonstrate genuine integration of immunology and cancer research;

2)      demonstrate clear line of sight to translation;

3)      be informed by patient and public involvement (all applications will be reviewed by OC patient advocates);

4)      increase Oxford’s immuno-oncology capacity;

5)      be used to leverage follow-on external funding.

Maximum amount per award: £20,000. Salaries will not be funded.

Award length: up to 12 months.